USANA Health Sciences, Inc.

NYSE:USNA

Packaged Foods

Consumer Defensive
$13.22 +3.83%

+$0.71 today

Market cap
$244.42M
Beta
0.77
P/E (TTM)
39.6
EPS (TTM)
$0.48
52W Low $16.60High $38.32

Volume 0.15M

Average 0.12M

USNA Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

USANA Health Sciences, Inc.NYSE: USNA

Depreciation & Amortization · Q1 FY2026 · quarter ended Apr 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $9.79M fell 4.5% year over year, behind the +43.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 4.8% from the prior quarter. Over 3 fiscal years it compounded at +15.0% a year.

Context

  • Depreciation & amortization amounted to 3.5% of revenue in FY2025, up 0.9 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -4.5% toward the trailing-twelve-month pace of +43.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$9.79M-4.8% QoQ
Last fiscal yearJan 2026
$32.56M+46.5% YoY
LTMApr 2026
$39.25M+43.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.5%——
1 year+46.5%——
3-year CAGR+15.0%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
32.56M USD
Year-over-year change
+46.5%
4-year CAGR
+10.1%

Depreciation & Amortization vs competitors

How USNA compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +43.3% is the 2nd highest of 8, against a peer median of -0.9%.
  • Depreciation & amortization amounts to 4.2% of revenue for USNA, versus a peer median of 3.5%.
USNA Competitors
Depreciation & Amortization for USNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DDLDingdong (Cayman) LimitedLTM Jun 2025CN¥114.6M CNY-26.1%-21.8%0.5%
BGSB&G Foods, Inc.LTM Apr 2026$86.83M USD-0.9%-3.9%4.8%
LNDBrasilAgro - Companhia Brasileira de Propriedades AgrícolasLTM Mar 2026R$67.3M BRL-28.9%-3.2%12.3%
WESTWestrock Coffee Company, LLCLTM Mar 2026$47.74M USD+22.6%+32.1%3.7%
USNAUSANA Health Sciences, Inc.LTM Apr 2026$39.25M USD+43.3%+15.0%4.2%
BRCCBRC Inc.LTM Mar 2026$11.78M USD+12.2%+40.7%2.8%
MAMAMama's Creations, Inc.LTM Apr 2026$6.63M USD+237.8%+40.5%3.5%
LWAYLifeway Foods, Inc.LTM Mar 2026$118K USD-96.7%+10.2%0.1%
Peer median (excluding USNA) —-0.9%+10.2%3.5%

Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income116.51M69.35M63.79M42.06M10.76M
Depreciation & Amortization22.19M21.41M20.4M22.23M32.56M
Deferred Income Tax(2.97M)(7.18M)(2.75M)(6.74M)(7.13M)
Stock-Based Compensation14.3M13.49M14.6M14.56M13.83M
Change in Working Capital(28.86M)771K(28M)(13M)(43.08M)
Accounts Receivables00000
Inventory(10.5M)15.8M2.35M(2.12M)(34.69M)
Accounts Payables(4.57M)(2.66M)(428K)(1.27M)5.2M
Other Working Capital(13.79M)(12.37M)(29.92M)(9.62M)(13.6M)
Other Non-Cash Items61K6.07M2.61M1.89M15.41M
Operating Cash Flow121.23M103.9M70.64M60.99M22.35M
Capital Expenditures(12.76M)(10.4M)(14.49M)(10.07M)(13.82M)
Acquisitions (Net)(1.94M)(6.53M)0(203.34M)0
Purchases of Investments(1.56M)0(1.27M)(870K)0
Sales of Investments1.94M4.56M3.78M1.13M0
Other Investing Activities131K7K15K64K3.7M
Investing Cash Flow(14.19M)(12.37M)(11.98M)(213.09M)(10.13M)
Debt Repayment00792K22.22M(9M)
Common Stock Issued00000
Common Stock Repurchased(177.84M)(25.38M)(11.6M)(9.44M)(27.51M)
Dividends Paid00000
Other Financing Activities(3.58M)(4.71M)(3.43M)(3.22M)(4.1M)
Financing Cash Flow(181.41M)(30.09M)(14.24M)9.55M(40.6M)
Effect of Forex Changes2.09M(13.78M)(2.5M)(6.19M)5.11M
Net Change in Cash(72.28M)47.67M41.93M(148.74M)(23.27M)
Free Cash Flow108.46M93.5M56.15M50.92M8.53M

USANA Health Sciences, Inc.

NYSE:USNA

Intrinsic Alpha fair value

Locked

Current Price

$13.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.